AIM ImmunoTech announced NCI award of $14.54 million to study Ampligen as part of five Roswell Park-led chemokine modulation clinical trials in melanoma, colorectal and ovarian cancers
| | | | |

AIM ImmunoTech announced NCI award of $14.54 million to study Ampligen as part of five Roswell Park-led chemokine modulation clinical trials in melanoma, colorectal and ovarian cancers

On Apr. 6, 2020, the National Cancer Institute awarded of $14.54 million to Roswell Park Comprehensive Cancer Center…

Pacific Health Research Institute was awarded the multi-center ‘Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial’
| | | | |

Pacific Health Research Institute was awarded the multi-center ‘Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial’

In 1992, the National Cancer Institute (NCI) awarded the Pacific Health Research Institute its largest and most enduring…

Albert Einstein Cancer Center’s Liver Research Center became the first institute in the nation devoted to the study of liver disease and injury
| | | | | | |

Albert Einstein Cancer Center’s Liver Research Center became the first institute in the nation devoted to the study of liver disease and injury

In 1974, Albert Einstein Cancer Center’s Liver Research Center — now the interdisciplinary Marion Bessin Liver Research Center…